quinidine has been researched along with MS (Multiple Sclerosis) in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fralick, M; Kesselheim, AS; Sacks, CA | 1 |
| Crumpacker, DW | 1 |
| Haiman, G; Miller, A; Pratt, H | 1 |
| Brooks, BR; Cummings, J; Hepner, A; Kaye, R; Pioro, EP; Schiffer, R; Thisted, RA; Wynn, D | 1 |
| Garnock-Jones, KP | 1 |
| Achiron, A; Berg, JE; Dietrich, DW; Fletcher, M; Mandler, RN; Miller, A; Panitch, HS; Pope, LE; Smith, RA; Thisted, RA; Vollmer, TL; Wymer, JP; Wynn, DR | 1 |
| Miller, A | 1 |
| Miller, A; Panitch, H | 1 |
4 review(s) available for quinidine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Enhancing Approaches to the Identification and Management of Pseudobulbar Affect.
Topics: Affective Symptoms; Crying; Dextromethorphan; Drug Combinations; Female; Humans; Laughter; Middle Aged; Multiple Sclerosis; Neurotransmitter Agents; Quinidine | 2016 |
Dextromethorphan/quinidine: in pseudobulbar affect.
Topics: Amyotrophic Lateral Sclerosis; Crying; Dextromethorphan; Drug Combinations; Emotions; Female; Humans; Laughter; Male; Mood Disorders; Multiple Sclerosis; Quinidine | 2011 |
Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.
Topics: Adrenergic alpha-Antagonists; Dextromethorphan; Emotions; Excitatory Amino Acid Antagonists; Humans; Mood Disorders; Multiple Sclerosis; Quinidine | 2006 |
Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.
Topics: Animals; Brain; Dextromethorphan; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Multiple Sclerosis; Pseudobulbar Palsy; Quinidine | 2007 |
2 trial(s) available for quinidine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Dextromethorphan; Dose-Response Relationship, Drug; Drug Combinations; Electrocardiography; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Oxygen; Quinidine | 2010 |
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
Topics: Affect; Aged; Crying; Dextromethorphan; Double-Blind Method; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Laughter; Male; Middle Aged; Multiple Sclerosis; Pain Measurement; Quality of Life; Quinidine | 2006 |
2 other study(ies) available for quinidine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.
Topics: Aged; Amyotrophic Lateral Sclerosis; Dementia; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Pseudobulbar Palsy; Quinidine; United States; United States Food and Drug Administration | 2019 |
Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect.
Topics: Acoustic Stimulation; Adult; Dextromethorphan; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pseudobulbar Palsy; Psychomotor Performance; Quinidine | 2009 |